Antibody recognizing n-domain of midkine
AssigneeCellmid Limited
InventorsSadatosi Sakuma, Maria Halasz, Darren Jones
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to isolated or recombinant proteins, such as antibodies, which inhibit or reduce the function of midkine (hereinafter, referred to as “MK”) for use in the treatment or prevention of midkine-related disorders.
Claims24
A method for treating or preventing a midkine-related disorder comprising administering to a subject in need thereof an isolated or recombinant protein comprising an antigen binding domain of an antibody which specifically binds to an epitope located within the N-domain of midkine (MK) as defined by amino acid residues 1-61 of SEQ ID NO:2, wherein the protein inhibits or reduces a function of MK.
-24. (canceled)
Dependencies are inferred from the claim text.